» Articles » PMID: 16123418

The Effect of Experimental Glaucoma and Optic Nerve Transection on Amacrine Cells in the Rat Retina

Overview
Specialty Ophthalmology
Date 2005 Aug 27
PMID 16123418
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To detect alterations in amacrine cells associated with retinal ganglion cell (RGC) depletion caused by experimental optic nerve transection and glaucoma.

Methods: Intraocular pressure (IOP) was elevated unilaterally in 18 rats by translimbal trabecular laser treatment, and eyes were studied at 1 (n = 6), 2 (n = 5), and 3 (n = 7) months. Complete optic nerve transection was performed unilaterally in nine rats with survival for 1 (n = 4) and 3 (n = 5) months. Serial cryosections (five per eye) were immunohistochemically labeled with rabbit anti-gamma-aminobutyric acid (GABA) and anti-glycine antibodies. Cells in the ganglion cell and inner nuclear layers that labeled for GABA or glycine were counted in a masked fashion under bright-field microscopy. Additional labeling with other RGC and amacrine antigens was also performed. RGC loss was quantified by axon counts.

Results: Amacrine cells identified by GABA and glycine labeling were not significantly affected by experimental glaucoma, with a mean decrease of 15% compared with bilaterally untreated control cells (557 +/- 186 neurons/mm [glaucoma] versus 653.9 +/- 114.4 neurons/mm [control] of retina; P = 0.15, t-test). There was no significant trend for amacrine cell counts to be lower in eyes with fewer RGCs (r = -0.39, P = 0.11). By contrast, there was highly significant loss of GABA and glycine staining 3 months after nerve transection, both in the treated and the fellow eyes (P < 0.0001, t-test). However, there was a substantial number of remaining amacrine cells in transected retinas, as indicated by labeling for calretinin and calbindin.

Conclusions: Experimental glaucoma causes minimal change in amacrine cells and their expression of neurotransmitters. After nerve transection, neurotransmitter presence declines, but many amacrine cell bodies remain. Differences among optic nerve injury models, as well as effects on "untreated" fellow eyes, should be recognized.

Citing Articles

Characterizing Presumed Displaced Retinal Ganglion Cells in the Living Human Retina of Healthy and Glaucomatous Eyes.

Marte M, Kurokawa K, Jung H, Liu Y, Bernucci M, King B Invest Ophthalmol Vis Sci. 2024; 65(11):20.

PMID: 39259176 PMC: 11401130. DOI: 10.1167/iovs.65.11.20.


IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors.

Pitha I, Du L, Nguyen T, Quigley H Prog Retin Eye Res. 2023; 99:101232.

PMID: 38110030 PMC: 10960268. DOI: 10.1016/j.preteyeres.2023.101232.


Selective vulnerability of the intermediate retinal capillary plexus precedes retinal ganglion cell loss in ocular hypertension.

Pitale P, Shen G, Sigireddi R, Polo-Prieto M, Park Y, Gibson S Front Cell Neurosci. 2022; 16:1073786.

PMID: 36545655 PMC: 9760765. DOI: 10.3389/fncel.2022.1073786.


Axonal architecture of the mouse inner retina revealed by second harmonic generation.

Meah A, Boodram V, Bucinca-Cupallari F, Lim H PNAS Nexus. 2022; 1(4):pgac160.

PMID: 36106183 PMC: 9463061. DOI: 10.1093/pnasnexus/pgac160.


In vivo and in vitro knockout system labelled using fluorescent protein via microhomology-mediated end joining.

Katayama S, Sato K, Nakazawa T Life Sci Alliance. 2019; 3(1).

PMID: 31874862 PMC: 6932181. DOI: 10.26508/lsa.201900528.


References
1.
Levkovitch-Verbin H, Quigley H, DAnna S, Kerrigan D, Pease M . Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2001; 42(5):975-82. View

2.
Bensaoula T, Shibuya H, Katz M, Smith J, Johnson G, John S . Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology. 2000; 107(9):1746-53. DOI: 10.1016/s0161-6420(00)00264-5. View

3.
Levkovitch-Verbin H, Quigley H, Martin K, Valenta D, Baumrind L, Pease M . Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002; 43(2):402-10. View

4.
Kolb H, Zhang L, Dekorver L, Cuenca N . A new look at calretinin-immunoreactive amacrine cell types in the monkey retina. J Comp Neurol. 2002; 453(2):168-84. DOI: 10.1002/cne.10405. View

5.
Schwartz M . Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2003; 44(4):1407-11. DOI: 10.1167/iovs.02-0594. View